Hypnotic and hypothermic action of daytime-administered melatonin

Abstract Six healthy male volunteers (average age = 22.5 years) received orally melatonin (MLT; 3 mg or 9 mg) or placebo at 0930 hours in a randomized, single-blind, cross-over study. Both doses of exogenously administered melatonin (ex-MLT) induced transient, significant suppression of core body temperature (BT) compared to the placebo condition. There was no significant difference in the degree of BT suppression among the two MLT conditions in spite of significantly higher levels of serum MLT with the close of 9 mg, suggesting that there may be a threshold level of ex-MLT inducing the hypothermic action. Daytime administered ex-MLT also induced a significant sleep-inducing effect only in the 9 mg condition, while 3 mg ex-MLT failed to produce statistical significance. These findings suggest that the sleep-inducing action of ex-MLT occurs only at relatively high doses, and this action is probably not due to its BT lowering action. The present study led us to assume that ex-MLT produce its therapeutic effect for circadian rhythm sleep disorders through induction of circadian phase-shifting preceded by an acute, transient hypothermic action rather than light entrainment after setting sleep time by induction of sleep propensity.

[1]  J. Jan,et al.  THE TREATMENT OF SLEEP DISORDERS WITH MELATONIN , 1994, Developmental medicine and child neurology.

[2]  L. Wetterberg,et al.  Correction of non–24‐hour sleep/wake cycle by melatonin in a blind retarded boy , 1991, Annals of neurology.

[3]  S. Folkard,et al.  Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms , 1990, Neuroscience Letters.

[4]  D Dawson,et al.  Improving adaptation to simulated night shift: timed exposure to bright light versus daytime melatonin administration. , 1995, Sleep.

[5]  A. Lewy,et al.  Melatonin shifts human circadian rhythms according to a phase-response curve. , 1992, Chronobiology international.

[6]  Lieberman Hr.  Behavior, sleep and melatonin. , 1986 .

[7]  M. Carskadon,et al.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. , 1986, Sleep.

[8]  M. Gillette,et al.  Melatonin directly resets the rat suprachiasmatic circadian clock in vitro , 1991, Brain Research.

[9]  D. J. Mullaney,et al.  Automatic sleep/wake identification from wrist activity. , 1992, Sleep.

[10]  Harris R. Lieberman,et al.  Effects of melatonin on human mood and performance , 1984, Brain Research.

[11]  S. Folkard,et al.  Some effects of jet-lag and their alleviation by melatonin , 1987 .

[12]  J. Parkes,et al.  Delayed sleep phase syndrome response to melatonin , 1991, The Lancet.

[13]  P. Lavie,et al.  The importance of timing in melatonin administration in a blind man , 1992, Journal of pineal research.

[14]  J. Arendt,et al.  Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans , 1994, Neuroscience Letters.

[15]  S. Yen,et al.  Melatonin: a major regulator of the circadian rhythm of core temperature in humans. , 1992, The Journal of clinical endocrinology and metabolism.

[16]  A. Lewy,et al.  Melatonin Administration to Blind People: Phase Advances and Entrainment , 1991, Journal of biological rhythms.

[17]  J R Ives,et al.  Sleep‐inducing effects of low doses of melatonin ingested in the evening , 1995, Clinical pharmacology and therapeutics.

[18]  R. Wurtman,et al.  Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Josephine Arendt,et al.  Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans , 1995, Brain Research.

[20]  A. Cagnacci,et al.  Melatonin-induced decrease of body temperature in women: a threshold event. , 1994, Neuroendocrinology.